首页> 外文期刊>Archivum Immunologiae et Therapiae Experimentalis >Dysregulation of the Receptor Activator of NF-κB Ligand and Osteoprotegerin Production Influence the Apoptosis of Multiple Myeloma Patients’ Bone Marrow Stromal Cells Co-Cultured with Myeloma Cells
【24h】

Dysregulation of the Receptor Activator of NF-κB Ligand and Osteoprotegerin Production Influence the Apoptosis of Multiple Myeloma Patients’ Bone Marrow Stromal Cells Co-Cultured with Myeloma Cells

机译:NF-κB配体受体激活剂的失调和骨保护素的产生影响多发性骨髓瘤患者骨髓培养的骨髓基质细胞凋亡

获取原文
获取原文并翻译 | 示例
           

摘要

The interaction of multiple myeloma (MM) cells and bone marrow stromal cells (BMSCs) induces profound changes in the bone marrow environment, influencing osteoclastogenesis and MM cell survival. Differences in receptor activator of NF-κB ligand (RANKL) and osteoprotegerin (OPG) production in BMSCs derived from MM patients and control subjects and the apoptosis of BMSCs and MM cells in co-cultures of both cell types were examined. RANKL and OPG expressions were examined by ELISA and semiquantitative RT-PCR. Apoptosis of BMSCs after contact with RPMI8226 and U266 cells was measured by flow cytometry and the level of ALP activity by the spectrophotometric method. OPG production by BMSCs was significantly inhibited after direct contact with RPMI8226 cells. Production of soluble RANKL was enhanced and the increase was more significant in the BMSCs of the MM patients than in those of the controls. In co-cultures of BMSCs and MM cells, significant apoptosis was detected with a concomitant decrease in ALP activity. This apoptosis decreased significantly in the presence of RANK-Fc, an antagonist of RANKL. Disturbances in the RANKL/OPG system are more profound in the BMSCs of MM patients than in those of control subjects after direct contact with RPMI8226 cells. Moreover, direct contact with RPMI8226 and U266 cells induces apoptosis of BMSCs which is mediated by an overproduction of RANKL.
机译:多发性骨髓瘤(MM)细胞和骨髓基质细胞(BMSC)的相互作用诱导了骨髓环境的深刻变化,影响了破骨细胞的生成和MM细胞的存活。在两种细胞类型的共培养物中,检查了源自MM患者和对照受试者的BMSC中NF-κB配体(RANKL)和骨保护素(OPG)的受体激活剂的差异以及BMSCs和MM细胞的凋亡。通过ELISA和半定量RT-PCR检查RANKL和OPG的表达。通过流式细胞术测定与RPMI8226和U266细胞接触后BMSC的凋亡,并通过分光光度法测定其ALP活性水平。直接接触RPMI8226细胞后,BMSC的OPG产生受到显着抑制。与对照组相比,MM患者的BMSCs中可溶性RANKL的产生增加,并且增加更为显着。在BMSC和MM细胞的共培养中,检测到显着的凋亡,同时ALP活性降低。在RANKL拮抗剂RANK-Fc的存在下,这种凋亡明显减少。直接接触RPMI8226细胞后,MM患者的BMSC中的RANKL / OPG系统中的干扰比对照对象中的干扰更严重。此外,直接接触RPMI8226和U266细胞会诱导BMSC的凋亡,这是由RANKL的过量生产介导的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号